Literature DB >> 21044876

Egr-1 regulates the transcriptional repression of mouse δ-aminolevulinic acid synthase 1 by heme.

Saki Gotoh1, Takayuki Nakamura, Takao Kataoka, Shigeru Taketani.   

Abstract

δ-Aminolevulinic acid synthase 1 (ALAS1) is the first and rate-limiting enzyme in the heme biosynthesis. It has been well known that heme exerts a negative feedback control over the transcription of ALAS1 gene to maintain intracellular heme at appropriate level. To clarify the mechanisms by which heme regulates the expression of ALAS1, we examined the promoter activity of the gene and identified the heme-responsive element (HRE) located in the proximal promoter of the mouse ALAS1 gene. Reporter and EMSA assays revealed the sequence (GCGGGGGCG), as the site of repression by heme, at -301/-293bp of the ALAS1 promoter. Subsequently, EMSA and ChIP assays showed that a transcription factor, early growth response 1 (Egr-1) and its major corepressors, NAB1 and NAB2 were found to bind to the ALAS1-HRE, and these bindings increased dependent on the level of intracellular heme. When Egr-1 and NAB1 in combination were expressed in the cells, decreases of the level of ALAS1 mRNA and intracellular level of heme were observed. These results suggest that Egr-1-NABs complex is involved in the regulation of the transcription of ALAS1 by heme, leading to the regulation of the heme biosynthesis. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21044876     DOI: 10.1016/j.gene.2010.10.008

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

Review 1.  5-Aminolevulinate synthase catalysis: The catcher in heme biosynthesis.

Authors:  Bosko M Stojanovski; Gregory A Hunter; Insung Na; Vladimir N Uversky; Rays H Y Jiang; Gloria C Ferreira
Journal:  Mol Genet Metab       Date:  2019-06-13       Impact factor: 4.797

2.  Liver Transplantation for Acute Intermittent Porphyria: Biochemical and Pathologic Studies of the Explanted Liver.

Authors:  Makiko Yasuda; Angelika L Erwin; Lawrence U Liu; Manisha Balwani; Brenden Chen; Senkottuvelan Kadirvel; Lin Gan; M Isabel Fiel; Ronald E Gordon; Chunli Yu; Sonia Clavero; Antonios Arvelakis; Hetanshi Naik; L David Martin; John D Phillips; Karl E Anderson; Vaithamanithi M Sadagoparamanujam; Sander S Florman; Robert J Desnick
Journal:  Mol Med       Date:  2015-06-05       Impact factor: 6.354

3.  Complex response to physiological and drug-induced hepatic heme demand in monoallelic ALAS1 mice.

Authors:  Viktoria Vagany; Susan Robinson; Tatyana Chernova; Andrew G Smith
Journal:  Mol Genet Metab Rep       Date:  2021-11-12

4.  Heme levels are increased in human failing hearts.

Authors:  Arineh Khechaduri; Marina Bayeva; Hsiang-Chun Chang; Hossein Ardehali
Journal:  J Am Coll Cardiol       Date:  2013-03-06       Impact factor: 24.094

5.  Coordinate expression of heme and globin is essential for effective erythropoiesis.

Authors:  Raymond T Doty; Susan R Phelps; Christina Shadle; Marilyn Sanchez-Bonilla; Siobán B Keel; Janis L Abkowitz
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

6.  Hypochlorite-modified high-density lipoprotein promotes induction of HO-1 in endothelial cells via activation of p42/44 MAPK and zinc finger transcription factor Egr-1.

Authors:  Christine Rossmann; Anamaria Rauh; Astrid Hammer; Werner Windischhofer; Sandra Zirkl; Wolfgang Sattler; Ernst Malle
Journal:  Arch Biochem Biophys       Date:  2011-02-24       Impact factor: 4.013

7.  Heme exporter FLVCR1a regulates heme synthesis and degradation and controls activity of cytochromes P450.

Authors:  Francesca Vinchi; Giada Ingoglia; Deborah Chiabrando; Sonia Mercurio; Emilia Turco; Lorenzo Silengo; Fiorella Altruda; Emanuela Tolosano
Journal:  Gastroenterology       Date:  2014-01-31       Impact factor: 22.682

8.  Toxicoproteomic Profiling of hPXR Transgenic Mice Treated with Rifampicin and Isoniazid.

Authors:  Christopher Trent Brewer; Kiran Kodali; Jing Wu; Timothy I Shaw; Junmin Peng; Taosheng Chen
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.